CD
Chandrasekhar Devunipalli
About Chandrasekhar Devunipalli
Data last updated:
Chandrasekhar Devunipalli is a Managing Director at Cetreno Pharmaceuticals Private Limited (since 2019). The company operates in Pharma. Cetreno Pharmaceuticals Private Limited reported revenue of ₹4.3 Lakh (FY 2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Cetreno Pharmaceuticals Private Limited U24100AP2019PTC111877 | Managing Director | 10 May 2019 | 2019 | ₹4.3 Lakh (FY 2020) | Active |
Board colleagues of Chandrasekhar Devunipalli
| Name | DIN | Company | Designation |
|---|---|---|---|
| Devunipalli Sarada | 08448822 | Cetreno Pharmaceuticals Private Limited | Director |
| Harini Pillalamarri | 08786699 | Cetreno Pharmaceuticals Private Limited | Director |
| Pillalamarri Kumar Roop | 08554826 | Cetreno Pharmaceuticals Private Limited | Director |
| Prasannaanjanikumari Velpuri | 08786701 | Cetreno Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chandrasekhar Devunipalli
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chandrasekhar Devunipalli
Chandrasekhar Devunipalli currently holds 1 directorship: Cetreno Pharmaceuticals Private Limited (Managing Director, since 10 May 2019, revenue ₹4.3 Lakh (FY 2020)).
Chandrasekhar Devunipalli was first appointed on 10 May 2019 as Managing Director at Cetreno Pharmaceuticals Private Limited.
The current boards of Chandrasekhar Devunipalli's companies include Devunipalli Sarada (Cetreno Pharmaceuticals Private Limited), Harini Pillalamarri (Cetreno Pharmaceuticals Private Limited), Pillalamarri Kumar Roop (Cetreno Pharmaceuticals Private Limited), Prasannaanjanikumari Velpuri (Cetreno Pharmaceuticals Private Limited).